PIR

Across TCGA pan-cancer cohorts, PIR Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated PIR data layer compared with 27 for mass-spec protein and 2 for mass-spec protein.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher PIR Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated PIR expression acts as an unfavorable survival marker.

SKCM, UCEC, and HNSC are the cancer types where PIR Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Median	All	0.209	0.728	.020	12	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →
HNSC	OS	Median	All	0.151	0.660	.015	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

PIR–SKCM (DFS)

Open the SKCM breakdown →